State Street CORP

Market Movers (8-K)

See all →
NYSE
State Street Corporation announced the issuance of $750 million in Fixed-to-Floating Rate Senior Notes due 2037, alongside its subsidiary's issuance of $1.25 billion in senior notes.
Capital raise
NYSE
State Street Corporation announced robust third-quarter 2026 results, showcasing record AUC/A and AUM, significant revenue growth, and progress on strategic initiatives.
Better than expected
NYSE
State Street Corporation has announced two key executive leadership appointments, effective immediately, to bolster its strategic operations.
NYSE
State Street Corporation announced the issuance and sale of 500,000 depositary shares representing preferred stock, raising approximately $495.7 million.
Capital raise
NYSE
State Street Bank and Trust Company has successfully issued $1.25 billion in senior notes across two tranches, maturing in 2029 and 2034, to fund its operations.
Capital raise
NYSE
State Street Corporation announced robust second-quarter 2026 financial results, showcasing record revenues and assets under custody and administration.
Better than expected

Quarterly Earnings (10-Q)

See all →
NYSE
State Street Corporation announced a 13% increase in total revenue for Q3 2026, driven by significant growth in fee revenue and net interest income, alongside improved profitability metrics.
NYSE
State Street Corporation announced a significant increase in total revenue and net income for the second quarter of 2026, driven by growth in fee revenue and net interest income.
Better than expected
NYSE
State Street Corporation reported a 9% increase in total revenue and a 23% jump in diluted earnings per share for the third quarter of 2025, driven by higher fee revenue and market levels.
Better than expected
Capital raise
NYSE
State Street Corporation announced an 8% increase in total revenue for the second quarter of 2025, driven by strong fee income, but net income declined 3% due to significant expense increases and higher credit loss provisions.
Capital raise
Worse than expected
NYSE
State Street's Q1 2025 earnings per share increased by 49% year-over-year, fueled by higher total revenue and lower expenses.
Better than expected
NYSE
State Street Corporation's Q3 2024 earnings surged, fueled by increased fee revenue, net interest income, and strategic portfolio adjustments, despite a rise in expenses.
Better than expected

Annual Reports (10-K)

NYSE
State Street Corporation announced a 7% increase in total revenue and significant growth in assets under custody and management for the fiscal year ended December 31, 2025.
Delay expected
Better than expected
Capital raise
NYSE
State Street Corporation's 2024 10-K filing reveals a robust financial performance, marked by increased fee revenue and net interest income, alongside strategic initiatives aimed at operational efficiency and technological advancement.
Delay expected
Capital raise
NYSE
State Street Corporation outlines the terms of its common and preferred stock, including redemption plans and voting rights, in a recent SEC filing.

Insider Trading (Form 4)

See all →
NYSE
Kathryn M Horgan, Executive Vice President of State Street Corp, sold 6,437 shares of common stock on November 11, 2026 for $173.88 per share.
NYSE
W. Bradford Hu, EVP and Chief Risk Officer of State Street Corp, sold 7,099 shares of common stock on October 26, 2026 for $168.63 per share.
NYSE
Karl Alexander Vollert, a Director of State Street Corp, reported a transaction in 118 shares of common stock on October 9, 2026.
NYSE
Hanley Ronald P O, Chairman, CEO and President and a Director of State Street Corp, sold 14,554 shares of common stock on October 20, 2026 for $164.60 per share.
NYSE
Karl Alexander Vollert, a Director of State Street Corp, received 784 shares of common stock on October 9, 2026.
NYSE
Michael L Richards, EVP and Chief Admin Officer of State Street Corp, reported a transaction in 1,009 shares of common stock on September 2, 2026.

Proxy Statements (Def-14A)

NYSE
State Street Corporation has announced its 2026 Annual Meeting of Shareholders will be held virtually on May 20, 2026, with key agenda items including director elections and executive compensation.
NYSE
State Street Corporation has filed a definitive proxy statement related to its upcoming shareholder meeting.
NYSE
State Street Corporation invites shareholders to its 2025 annual meeting and highlights a strong 2024 performance driven by revenue growth and strategic investments.
Better than expected
NYSE
State Street Corporation has filed a definitive proxy statement related to its upcoming shareholder meeting.
NYSE
State Street Corporation's proxy statement details the agenda for the 2024 annual meeting, director nominees, executive compensation, and corporate governance practices.
Worse than expected

Institutional Holdings (13F)

See all →
NYSE
State Street Corp reported 4,310 holdings worth $3,435.6B for the period ended September 30, 2026.
NYSE
State Street Corp reported 4,261 holdings worth $3,383.3B for the period ended June 30, 2026.
NYSE
State Street Corp reported 4,177 holdings worth $3,371.2B for the period ended June 30, 2026.
NYSE
This SEC Form 13F filing provides a snapshot of institutional investment holdings as of the reporting period.
NYSE
State Street Corp. has filed its quarterly 13F-HR report, revealing its substantial equity holdings totaling nearly $3 trillion as of December 31, 2025.
NYSE
State Street Corp has filed its quarterly report detailing $2.88 trillion in equity holdings across 4,282 positions as of September 30, 2025.

Schedule 13G - Passive Investments

See all →
NYSE
State Street Corporation has updated its beneficial ownership filing for Wolfspeed Inc., reporting a significant holding of common stock.
NYSE
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 6% of Voyager Technologies Inc. common stock as of September 30, 2026.
NYSE
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 4,876,395 shares, or 4.3%, of Viridian Therapeutics Inc. common stock as of September 30, 2026.
NYSE
State Street Corporation and SSGA Funds Management, Inc. have filed a Schedule 13G, reporting their beneficial ownership of Virgin Galactic Holdings Inc. common stock.
NYSE
State Street Corporation has disclosed a beneficial ownership of 4.6% in Vir Biotechnology Inc. as of September 30, 2026.
NYSE
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 4.4% of Verastem Inc.'s common stock as of September 30, 2026.